Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Aug
10
2020
“Buy American” in the Twilight Zone: Executive Order Strengthening the U.S. Public Health Industrial Base Sheppard, Mullin, Richter & Hampton LLP
Aug
10
2020
FDA Publishes Report on Nanotechnology — Over a Decade of Progress and Innovation, Will Hold Webinar on August 13 Bergeson & Campbell, P.C.
Aug
10
2020
FDA Requests Information That Could Result in Expanding the Rarely Consumed Raw (RCR) List of Produce Commodities Exempt From the Produce Safety Rule Keller and Heckman LLP
Aug
7
2020
EEOC Issues Guidance on Opioid Use by Employees Barnes & Thornburg LLP
Aug
7
2020
DOJ Secures Admission of Guilt, Agrees to Deferred Prosecution Agreement for Generic Drug Manufacturer Accused of Price Fixing MoginRubin
Aug
7
2020
U.S. Senate Passes The Sustainable Chemistry Research And Development Act Bergeson & Campbell, P.C.
Aug
7
2020
EFSA Draft Guidance on Small Particles including Nanoparticles in Regulated Food and Feed Applications May be Useful for Assessment of Nanoparticles in FCMs Keller and Heckman LLP
Aug
7
2020
Industry to Voluntarily Phase-Out Certain PFAS Used in Food Packaging Keller and Heckman LLP
Aug
7
2020
FDA Issues Guidance on Action Level for Inorganic Arsenic in Infant Rice Cereals Keller and Heckman LLP
Aug
7
2020
CMS Proposes Additional Cuts to Part B Reimbursement of 340B Drugs Mintz
Aug
7
2020
EPA Issues SSURO against EcoShield LLC for Selling an Unregistered Product Claiming Effectiveness against SARS-CoV-2 Bergeson & Campbell, P.C.
Aug
7
2020
Food Hygiene Regulation to be updated before the end of the year Keller and Heckman LLP
Aug
6
2020
Telehealth and Substance Use Disorder Treatment: State Law Issues
Aug
6
2020
New York State Legislation Authorizes Manufacture and Sale of Ice Cream and Frozen Desserts Made with Liquor Keller and Heckman LLP
Aug
6
2020
FDA Greenlights Updates to the Purple Book Database Mintz
Aug
4
2020
340B Rate Cuts Are Legal, D.C. Circuit Court Holds Mintz
Aug
4
2020
FDA Issues COVID-19 Guidance to U.S. Exporters of Food Products Keller and Heckman LLP
Aug
4
2020
EPA Awards $4 Million to Develop New Approaches for Evaluating Chemical Toxicokinetics Bergeson & Campbell, P.C.
Aug
3
2020
COVID-19 Brings Consumer Convenience to Pennsylvania Norris McLaughlin P.A.
Aug
3
2020
FDA Issues Long-Awaited Draft Guidance on Cannabis Research
Aug
3
2020
FDA Releases a New EPA-Approved Protocol for Evaluating the Efficacy of Antimicrobial Pesticides in Agricultural Water Keller and Heckman LLP
Jul
31
2020
McDermottPlus Check-Up: July 31, 2020 McDermott Will & Emery
Jul
31
2020
EPA Announces the Approval of 13 Additional Products Effective against SARS-CoV-2 Bergeson & Campbell, P.C.
Jul
30
2020
FDA Sends Warning Letters to Companies Illegally Selling Hangover Supplements Keller and Heckman LLP
Jul
30
2020
Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic Foley & Lardner LLP
Jul
30
2020
Pizza Boxes Are Recyclable, According to New Study Keller and Heckman LLP
Jul
29
2020
August 13, 2020 Deadline for Healthcare Providers and Life Sciences Federal Contractors: Ban on Use of Certain Chinese Telecommunications Equipment and Services McDermott Will & Emery
Jul
29
2020
US House Appropriates $3.2 Billion for FDA for Fiscal Year 2021 Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins